InvestorsHub Logo
Followers 113
Posts 11274
Boards Moderated 2
Alias Born 02/06/2005

Re: kugel post# 7

Wednesday, 03/11/2015 10:27:30 AM

Wednesday, March 11, 2015 10:27:30 AM

Post# of 150
NEWTON, Mass., Feb. 23, 2015 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (KPTI), a clinical-stage pharmaceutical company, today announced that Nature Neuroscience published data showing Karyopharm's first-in-class oral Selective Inhibitor of Nuclear Export, or SINE(TM), compounds reduce the progression of multiple sclerosis (MS) in preclinical models.

http://www.fiercebiotechresearch.com/press-releases/nature-neuroscience-publishes-data-demonstrating-potential-therapeutic-bene
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent KPTI News